Embryo cleavage rate
The impact of incorporating DMSO and ionomycin into the spermatozoa’s
in vitro fertilization medium on the embryo cleavage rate following oocyte fertilization was the focus of the current investigation.
The embryo cleavage rate was significantly (P<0.05) higher in control (67.1%), DMSO (66.3%) and ionomycin 25 nM (69.5%) groups compared to ionomycin 50 nM (56.8%), as shown in Table 2.
The average number of embryos during the stage of development
The number of embryos at each cleavage stage was determined at the end of the seventh day of embryo culture. Degenerated oocytes in the 50 nM ionomycin group (17.8%), were significantly higher (P<0.05) than in control (13.3%), DMSO (13.5%) and ionomycin 25 nM (13.6%) groups. Additionally, the experimental 25 nM ionomycin group had a significantly (P<0.05) lower percentage of non-cleavage oocytes (one cell) than the 50 nM ionomycin group (16.9% vs. 25.4%). Furthermore, the percentage of fragmented embryos in both the control group (18.2%) and the DMSO group (18.1%) was significantly higher (P<0.05), than both 25 nM ionomycin (9.8%) and 50 nM ionomycin (11.7%) groups. Most of the embryos in the 50 nM ionomycin group (14.0%) were in the 2-cell stage but the blastocysts were on the same level, which was significantly higher (P<0.05) compared to the control (3.7%), DMSO (4.0%) and 25 nM ionomycin (2.1%) groups. As for the 4-cell stage, it was significantly (P<0.05) lower in the experimental 25 nM ionomycin group (2.1%) compared to the experimental 50 nM ionomycin group (6.0%). In addition, the blastocyst was significantly (P<0.05) higher in the 25 nM ionomycin group (71.5%), compared to the control (50.6%), DMSO (51.4%) and 50 nM ionomycin (36.9%) groups. As demonstrated in Table 1, there was no statistically significant difference between any of the groups regarding the percentage of embryos at the 8 and 16-cell stages, as well as at the morula stage.
Embryo arrival rate to the blastocyst
The current study examined the impact of the addition of DMSO and ionomycin to IVF medium on the cleavage rate and blastocyst rate on the seventh day from embryo culture.
In this experiment, the blastocyst rate was significantly (P<0.05) higher in the 25 nM ionomycin group (71.5%), compared to the control (50.6%), DMSO (51.4%) and 50 nM ionomycin (36.9%) groups. In addition, the expanded blastocyst rate was significantly (P<0.05) higher in the 25 nM ionomycin group (34.5%), compared to control (22.3%), DMSO (22.7%) and 50 nM ionomycin (14.0%) groups. In addition, the rate of hatching blastocyst was significantly (P<0.05) higher in the 25 nM ionomycin group (20.9%), compared to control (13.3%), DMSO (13.0%) and 50 nM ionomycin (11.2%) groups. In addition, as shown in Table 2 and Fig 1, the control (15.0%), DMSO (15.7%) and 25 nM ionomycin (16.2%) groups all had significantly (P<0.05) greater rates of hatched blastocysts than the 50 nM ionomycin group (11.7%).
The capacitation process requires the removal of inhibitors from the sperm head, an increase in intracellular pH and a decrease in the cholesterol/phospholipid ratio of the membranes, allowing them to be more permeable to calcium ions (
Langlais and Roberts, 1985). Our study objective is to improve the efficiency of
in vitro fertilization by increasing the cleavage rate and development of bovine embryos by studying the effect of adding; DMSO, 25 nM and 50 nM ionomycin to the sperm capacitation medium. The results of this study contradict those of
Hong et al., (2020), who utilized 5 mM ionomycin to the
in vitro maturation medium and goat ova embryo development and discovered no significant differences between the experimental group and the control group. This might be a result of the differing ionomycin concentrations they employed in their investigation or because they added the ionomycin to the maturation medium rather than the capacitation medium. Although it was discovered that ionomycin activated mouse oocyte and embryo development
(Heytens et al., 2008). Additionally, according to
Navarrete (2017), the calcium and metabolism in sperm are thought to play a key role in fertilization and embryo development. While our result agrees with
Slonina et al., (1995) who used the Ca
2+ A23187 for stallion sperm capacitation and found that the sperm exposed to A23187 had a significantly higher occurrence of acrosome reactions than sperm capacitated without Ca
2+ A23187 (p<0.01).
Increased Ca
2+ influx brought on by the acrosome reaction (AR) leads to higher Ca
2+ concentrations inside cells. This increase in Ca
2+ enables dephosphorylation/activation of p-gelsolin resulting in the dispersion of F-actin, allowing the plasma membrane PM and outer acrosome membrane OAM to come into close proximity and undergo fusion (
Breitbart and Shabtay, 2018).
The sperm capacitation process requires protein kinase A activation (PKA), changes in membrane potential and an increase in intracellular calcium (Ca
2+). Inhibition of these pathways results in loss of fertilizing ability
in vivo and
in vitro. According to
Nakagawa et al., (2001) and
Lu et al., (2006), the greater concentration (50 nM) of ionomycin may increase the likelihood of danger in sperm
in vitro capacitation, IVF and/or embryo development, necessitating further research. Despite the lack of conclusive proof of calcium ionophore toxicity on gametes and embryos, given the widespread application of the treatment in human oocytes, there could still be some concerns. However, according to
Spandorfer et al., (2001), the main cause of IVF failure seems to be the sperm’s incapability to penetrate the oocyte membrane, which demands for further research.